2019
DOI: 10.1080/23279095.2019.1628761
|View full text |Cite
|
Sign up to set email alerts
|

Symptom and performance validation in patients with subjective cognitive decline and mild cognitive impairment

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
5
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
9

Relationship

2
7

Authors

Journals

citations
Cited by 15 publications
(5 citation statements)
references
References 52 publications
0
5
0
Order By: Relevance
“…About the inclusion of bona fide patients, most of the studies have assumed that the clinical patients included in the clinical control group are bona fide, and the presence of possible incentives has not been assessed. As noted by Czornik et al (2021), in populations with reported mental disorders, diagnoses based on patients’ symptom presentation are common, and even in the clinical setting hidden agendas may be identified that may influence such presentation (Dandachi-FitzGerald et al, 2011, 2016). This problem is even more significant in self-reported SVTs and makes it difficult to distinguish between true and false positives.…”
Section: Discussionmentioning
confidence: 99%
“…About the inclusion of bona fide patients, most of the studies have assumed that the clinical patients included in the clinical control group are bona fide, and the presence of possible incentives has not been assessed. As noted by Czornik et al (2021), in populations with reported mental disorders, diagnoses based on patients’ symptom presentation are common, and even in the clinical setting hidden agendas may be identified that may influence such presentation (Dandachi-FitzGerald et al, 2011, 2016). This problem is even more significant in self-reported SVTs and makes it difficult to distinguish between true and false positives.…”
Section: Discussionmentioning
confidence: 99%
“…Alternatively, a screening-level cut score (with a false-positive rate of less than 10%) was established at seven or more endorsed pseudosymptoms. The authors (Czornik et al, 2021) could recently demonstrate a satisfying resistance of SRSI pseudosymptom items against the presence of milder forms of cognitive impairment.…”
Section: Instrumentsmentioning
confidence: 98%
“…Individuals were classified as cognitively impaired/dementia if they scored below − 1.5 standard deviations on any of the composite scores (dementia if they also had impaired daily living activities). This cut-off is frequently used to define mild cognitive impairment (MCI), it allows for the identification of a large number of cases qualifying for this diagnosis [45][46][47] and the diagnosis made using this cut-of has been significantly associated with measures of medial temporal atrophy and APOE genotype status [48]. These two diagnoses were further confirmed by an interview with their family.…”
Section: Measures and Proceduresmentioning
confidence: 99%